We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$618M
AUM Growth
+$34.4M
Cap. Flow
-$12M
Cap. Flow %
-1.95%
Top 10 Hldgs %
23.3%
Holding
492
New
15
Increased
–
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
APLS
Apellis Pharmaceuticals
APLS
+$318K
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$259K
3
MAN icon
ManpowerGroup
MAN
+$241K
4
UHS icon
Universal Health Services
UHS
+$236K
5
IR icon
Ingersoll Rand
IR
+$225K

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.1M
2
CTXS
Citrix Systems Inc
CTXS
+$2.08M
3
KLAC icon
KLA
KLAC
+$1.36M
4
ORCL icon
Oracle
ORCL
+$912K
5
ITW icon
Illinois Tool Works
ITW
+$745K

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 15.2%
3 Financials 13.94%
4 Industrials 12.19%
5 Consumer Discretionary 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGA icon
426
Reinsurance Group of America
RGA
$15.5B
$203K 0.03%
+1,429
New +$200K
DOC
427
DELISTED
PHYSICIANS REALTY TRUST
DOC
$203K 0.03%
14,000
– –
XXII
428
22nd Century Group
XXII
$1.49M
– –
0
– –
X
429
DELISTED
US Steel
X
$200K 0.03%
+8,000
New +$184K
ECHO
430
EchoStar
ECHO
$26B
$200K 0.03%
12,000
– –
GIII icon
431
G-III Apparel Group
GIII
$1.53B
$192K 0.03%
14,000
– –
ADTN icon
432
Adtran
ADTN
$640M
$188K 0.03%
10,000
– –
NXGN
433
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$188K 0.03%
10,000
– –
GDOT icon
434
Green Dot
GDOT
$766M
$174K 0.03%
11,000
– –
KW
435
DELISTED
Kennedy-Wilson Holdings
KW
$168K 0.03%
10,700
– –
XRX icon
436
Xerox
XRX
$438M
$161K 0.03%
11,000
– –
TGI
437
DELISTED
Triumph Group
TGI
$158K 0.03%
15,000
– –
PETQ
438
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$157K 0.03%
17,000
– –
TPC
439
Tutor Perini Cor
TPC
$5.35B
$151K 0.02%
20,000
– –
NVRI icon
440
Enviri
NVRI
$645M
$151K 0.02%
24,000
– –
XRN
441
Chiron Real Estate Inc
XRN
$470M
$149K 0.02%
3,140
– –
SBRA icon
442
Sabra Healthcare REIT
SBRA
$5.37B
$145K 0.02%
11,703
– –
UIS icon
443
Unisys
UIS
$216M
$141K 0.02%
27,500
– –
ARLO icon
444
Arlo Technologies
ARLO
$1.71B
$140K 0.02%
40,000
– –
LILAK icon
445
Liberty Latin America Class C
LILAK
$1.68B
$135K 0.02%
19,543
– –
GNL icon
446
Global Net Lease
GNL
$1.92B
$131K 0.02%
10,400
– –
WOW
447
DELISTED
WideOpenWest
WOW
$118K 0.02%
13,000
– –
MG icon
448
Mistras Group
MG
$499M
$118K 0.02%
24,000
– –
FIP icon
449
FTAI Infrastructure
FIP
$402M
$118K 0.02%
40,000
– –
VISN
450
Vistance Networks Inc
VISN
$2.38B
$118K 0.02%
16,000
– –
16 17
18
19 20

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q4 2022 Portfolio in Review

As of Q4 2022, NJ State Employees Deferred Compensation Plan held 492 positions worth $618M, up 5.9% from $584M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. NJ State Employees Deferred Compensation Plan opened 15 new positions and exited 9, leaving the 492-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • NJ State Employees Deferred Compensation Plan's largest Q4 2022 buy was Apellis Pharmaceuticals: 6,000 shares worth $310K.
  • NJ State Employees Deferred Compensation Plan's biggest Q4 2022 reduction was KLA, cutting an estimated $1.36M.
  • NJ State Employees Deferred Compensation Plan fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $3.1M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 23% of its $618M portfolio in Q4 2022.
  • NJ State Employees Deferred Compensation Plan opened 15 new positions and closed 9 in Q4 2022.
  • NJ State Employees Deferred Compensation Plan's portfolio value rose 5.9% quarter-over-quarter to $618M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2022, filed 26 Jan 2023.